These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16892335)

  • 1. Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120.
    Gopi HN; Tirupula KC; Baxter S; Ajith S; Chaiken IM
    ChemMedChem; 2006 Jan; 1(1):54-7. PubMed ID: 16892335
    [No Abstract]   [Full Text] [Related]  

  • 2. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT; Meyer B
    Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract]   [Full Text] [Related]  

  • 3. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
    Mori T; Shoemaker RH; Gulakowski RJ; Krepps BL; McMahon JB; Gustafson KR; Pannell LK; Boyd MR
    Biochem Biophys Res Commun; 1997 Sep; 238(1):218-22. PubMed ID: 9299482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1.
    Berkower I; Murphy D
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1055-65. PubMed ID: 8466484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
    Li H; Song H; Heredia A; Le N; Redfield R; Lewis GK; Wang LX
    Bioconjug Chem; 2004; 15(4):783-9. PubMed ID: 15264865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HIV and glycosylation].
    Nakata M; Mizuochi T
    Tanpakushitsu Kakusan Koso; 1998 Dec; 43(16 Suppl):2567-73. PubMed ID: 9883688
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic mimetics of the CD4 binding site of HIV-1 gp120 for the design of immunogens.
    Franke R; Hirsch T; Overwin H; Eichler J
    Angew Chem Int Ed Engl; 2007; 46(8):1253-5. PubMed ID: 17211914
    [No Abstract]   [Full Text] [Related]  

  • 10. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
    Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues.
    Bewley CA; Ray S; Cohen F; Collins SK; Overman LE
    J Nat Prod; 2004 Aug; 67(8):1319-24. PubMed ID: 15332849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin.
    Daly NL; Chen YK; Rosengren KJ; Marx UC; Phillips ML; Waring AJ; Wang W; Lehrer RI; Craik DJ
    Biochemistry; 2007 Sep; 46(35):9920-8. PubMed ID: 17685559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
    Sivan SK; Vangala R; Manga V
    Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization of a 2'F-RNA aptamer that binds a HIV-1 SU glycoprotein, gp120.
    Sayer N; Ibrahim J; Turner K; Tahiri-Alaoui A; James W
    Biochem Biophys Res Commun; 2002 May; 293(3):924-31. PubMed ID: 12051747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth.
    Huang CC; Stricher F; Martin L; Decker JM; Majeed S; Barthe P; Hendrickson WA; Robinson J; Roumestand C; Sodroski J; Wyatt R; Shaw GM; Vita C; Kwong PD
    Structure; 2005 May; 13(5):755-68. PubMed ID: 15893666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the HIV gp120 conserved domain 5 in processing and viral entry.
    Sen J; Jacobs A; Caffrey M
    Biochemistry; 2008 Jul; 47(30):7788-95. PubMed ID: 18597484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic alcohol drinking on receptor-binding, internalization, and degradation of human immunodeficiency virus 1 envelope protein gp120 in hepatocytes.
    Singh AK; Jiang Y; Gupta S
    Alcohol; 2007 Dec; 41(8):591-606. PubMed ID: 17980997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors.
    Teixeira C; Serradji N; Maurel F; Barbault F
    Eur J Med Chem; 2009 Sep; 44(9):3524-32. PubMed ID: 19410340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
    McFadden K; Cocklin S; Gopi H; Baxter S; Ajith S; Mahmood N; Shattock R; Chaiken I
    Proteins; 2007 May; 67(3):617-29. PubMed ID: 17348010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.